Deals - Page 2

Latham, Kirkland shepherd CyberArk’s $1.5bn Venafi acquisition

Latham guides CyberArk in acquisition of cybersecurity business from Kirkland-repped Thoma Bravo

  • 2mos

Latham, Skadden and Paul Weiss among firms advising on $6.9bn Squarespace take private


Private equity firm Permira is leading the deal, with support from General Atlantic and Accel

  • 2mos
Deals | US

Greenberg, Goodwin shepherd Ono Pharma’s $2.4bn Deciphera acquisition

Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence

  • 2mos

Kirkland, Latham shepherd Thoma Bravo’s £4.3bn Darktrace acquisition

Kirkland acts for marquee client Thoma Bravo as Latham counsels UK-listed cyber security company

  • 3mos
Deals | UK

Reed Smith, Shoosmiths lead on Concord’s £1.1bn Hipgnosis takeover

DLA Piper and Latham also called in for deal to save embattled song fund

  • 3mos
Deals | UK

Paul Hastings, Weil called in for sale of majority stake in Edinburgh Airport

Paul Hastings acts for buyer Vinci in £1.27bn deal as Weil counsels seller Global Infrastructure Partners

  • 3mos
Deals | UK

Skadden, Slaughter and May lead on International Paper’s £5.8bn DS Smith acquisition

Deal sees Skadden-repped International Paper beat earlier offer from British rival Mondi

  • 3mos
Deals | UK

Freshfields, Fenwick & West advise on Johnson & Johnson’s $13.1bn acquisition of Shockwave

Purchase of heart tech-maker Shockwave Medical is latest in series of deals to bolster J&J’s cardiac health division

  • 3mos
Deals | US

Skadden tops M&A league rankings in first quarter as deal value rebounds

Wachtell and Paul Weiss follow closely behind as megadeals contribute to 38% rise in global deal value

  • 3mos
Deals | US

Paul Hastings advises on Trump-linked Truth Social SPAC merger

Nelson Mullins also advised on the deal, which propelled the value of Trump’s Truth Social stake to $4.6bn

  • 4mos
Deals | US

Freshfields, Goodwin lead on AstraZeneca’s $2bn acquisition of Fusion Pharma

Deal second this month to see Freshfields advise acquisitive AstraZeneca

  • 4mos
Deals | UK

Kirkland, Latham shepherd EQT’s $35bn Equitrans gas merger

Last year’s top M&A firms lead as flurry of US oil and gas dealmaking continues

  • 4mos
Deals | US

Linklaters, Slaughters lead on Mondi’s £5bn DS Smith bid

Linklaters acts for Mondi in deal to create £10bn packaging giant as global M&A surges after 2023’s slump

  • 4mos
Deals | UK

Clifford Chance, Slaughter and May lead on Nationwide’s proposed £2.9bn Virgin Money bid

Slaughters advises Nationwide on deal to create UK’s second-largest savings and mortgage provider as CC reps Virgin Money

  • 4mos
Deals | UK

Global dealmakers expect M&A disputes to increase on economic, geopolitical woes

Berkeley Research Group survey shows that digital assets, energy and ESG will be key disputes areas in 2024

  • 4mos
Deals | US

Wachtell, Vinson & Elkins and Latham lead on Chord’s $11bn Enerplus merger

Canadian firms Goodmans and Blake Cassels & Graydon also advise as consolidation in US gas and oil industry continues apace

  • 5mos
Deals | US

Wachtell, Sullivan & Cromwell guide Capital One’s $35bn Discover acquisition

Biggest global M&A deal since start of 2024 continues rebound in megadeals following fallow 2023

  • 5mos
Deals | US

Wachtell, Paul Weiss and Vinson & Elkins shepherd Diamondback’s $26bn Endeavor acquisition

Wachtell acts for Diamondback on acquisition that will make it third-biggest producer in largest US oilfield

  • 5mos
Deals | US

Freshfields and Hogan Lovells advise on Barclays’ £600m Tesco Bank deal

Tesco to unload credit card, loan businesses to Barclays, with the two companies also entering into a 10-year distribution deal

  • 5mos
Deals | UK

Global M&A set to rebound in 2024, study finds

Survey of senior executives by Norton Rose Fulbright and Mergermarket points to ‘more active global M&A market’

  • 5mos
Deals |
Top